Bonus Issues

GLAND PHARMA LTD.

NSE : GLANDBSE : 543245ISIN CODE : INE068V01023Industry : Pharmaceuticals & DrugsHouse : Private
BSE1830.0010.25 (+0.56 %)
PREV CLOSE ( ) 1819.75
OPEN PRICE ( ) 1830.20
BID PRICE (QTY) 1827.25 (31)
OFFER PRICE (QTY) 1831.65 (2)
VOLUME 3277
TODAY'S LOW / HIGH ( )1805.70 1842.50
52 WK LOW / HIGH ( )861.5 2195.75
NSE1824.253.75 (+0.21 %)
PREV CLOSE( ) 1820.50
OPEN PRICE ( ) 1843.35
BID PRICE (QTY) 1824.15 (12)
OFFER PRICE (QTY) 1825.60 (7)
VOLUME 39445
TODAY'S LOW / HIGH( ) 1803.25 1848.40
52 WK LOW / HIGH ( )861 2194

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.